PubMed Health⌕ Search

Biomedical subjects

Teruko Ohtake

Publications and source records attributed to Teruko Ohtake.

3 recordsLinked to original sources
PubMed2005

[Analysis of small dense LDL in patients with type 2 diabetic mellitus by the modified Krauss method using an internal standard].

In patients with Type 2 diabetes mellitus (Type 2 DM), the relationship between the prevalence rate of small dense LDL (sdLDL) and parameters of lipid metabolism was analyzed using the method devised by modified Krauss method using apoferritin as an internal standard. The prevalence rate of sdLDL was 34% compared with it of normal subjects in this study. When the severity of Type 2 DM was classified into three groups of the HbA1c value, neither the sdLDL size nor its prevalence rate differed significantly depending upon the severity of the Type 2 DM. Also, when the prevalence rate of sdLDL was analyzed in relation to the severity of complications, i.e., of microangiopathy (retinopathy and nephropathy) or macroangiopathy (cerebral infarction), there was no significant difference in the prevalence rate of sdLDL depending on the severity of any of these complications. On the other hand, the prevalence rate of sdLDL was found to be correlated with the serum TG level. The serum level of TG-rich remnants (metabolites of TG) was also high in patients with sdLDL. It should take notice that the assessment of sdLDL should be used the authorized method for the evaluation. Thus it is concluded that the levels of sdLDL were important in evaluation of Type 2 DM. The prevalence rate of sdLDL did not correlate with the severity, nor the modalities for the complications of Type 2 DM.

Aged↗
PubMed2003

[Pitfalls in laboratory testing for autoantibodies].

Quantitative autoantibody determination has recently can be widely used to confirm the diagnosis of autoimmune diseases, however, there are several problems with the assay methods. As pitfalls in terms of measurement methods, in this report we describe actual examples of a problem related to the analysis and of a large discrepancy between the data obtained by different methods of measurement. In the first example, the reaction solution in the microplate evaporated during the reaction process in automated analysis using an Eitest CA-RF ELISA kit, causing the values in the outermost wells to be significantly higher than in the inner wells. In the second example, there was a large discrepancy between the values obtained when the anti-dsDNA antibody of a systemic lupus erythematosus(SLE) patient was measured by radioimmunoassay(RIA) and by enzyme-linked immunosorbent assay(ELISA). The reason for the discrepancy in the second example may have been related to the method of the RIA, which used 50% ammonium sulfate in the B/F separation, and the possibility that certain patients have autoantibody that recognizes the ELISA solid-phase antigen more strongly. Accordingly, quantitative assay data for anti-dsDNA antibody, which possesses such diversity, should be evaluated with due consideration of the characteristics of the assay method and by checking them against the clinical data.

Antibody Diversity↗